Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.

Identifieur interne : 004E19 ( Ncbi/Merge ); précédent : 004E18; suivant : 004E20

Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.

Auteurs : Michael A. Davies [États-Unis] ; Philippe Saiag [France] ; Georgina V. Long [Australie]

Source :

RBID : pubmed:28884697
DOI: 10.1016/S1470-2045(17)30640-X
PubMed: 28884697

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:28884697

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.</title>
<author>
<name sortKey="Davies, Michael A" sort="Davies, Michael A" uniqKey="Davies M" first="Michael A" last="Davies">Michael A. Davies</name>
<affiliation wicri:level="2">
<nlm:affiliation>Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mdavies@mdanderson.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Saiag, Philippe" sort="Saiag, Philippe" uniqKey="Saiag P" first="Philippe" last="Saiag">Philippe Saiag</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Boulogne-Billancourt</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Long, Georgina V" sort="Long, Georgina V" uniqKey="Long G" first="Georgina V" last="Long">Georgina V. Long</name>
<affiliation wicri:level="4">
<nlm:affiliation>Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW</wicri:regionArea>
<orgName type="university">Université de Sydney</orgName>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28884697</idno>
<idno type="pmid">28884697</idno>
<idno type="doi">10.1016/S1470-2045(17)30640-X</idno>
<idno type="wicri:Area/PubMed/Corpus">000610</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000610</idno>
<idno type="wicri:Area/PubMed/Curation">000608</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000608</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000608</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000608</idno>
<idno type="wicri:Area/Ncbi/Merge">004E19</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.</title>
<author>
<name sortKey="Davies, Michael A" sort="Davies, Michael A" uniqKey="Davies M" first="Michael A" last="Davies">Michael A. Davies</name>
<affiliation wicri:level="2">
<nlm:affiliation>Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mdavies@mdanderson.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Saiag, Philippe" sort="Saiag, Philippe" uniqKey="Saiag P" first="Philippe" last="Saiag">Philippe Saiag</name>
<affiliation wicri:level="3">
<nlm:affiliation>Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Boulogne-Billancourt</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Long, Georgina V" sort="Long, Georgina V" uniqKey="Long G" first="Georgina V" last="Long">Georgina V. Long</name>
<affiliation wicri:level="4">
<nlm:affiliation>Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW</wicri:regionArea>
<orgName type="university">Université de Sydney</orgName>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Lancet. Oncology</title>
<idno type="eISSN">1474-5488</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="In-Data-Review" Owner="NLM">
<PMID Version="1">28884697</PMID>
<DateCreated>
<Year>2017</Year>
<Month>09</Month>
<Day>08</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>09</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1474-5488</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2017</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Lancet. Oncology</Title>
<ISOAbbreviation>Lancet Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.</ArticleTitle>
<Pagination>
<MedlinePgn>e509</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1470-2045(17)30640-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(17)30640-X</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mdavies@mdanderson.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saiag</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Long</LastName>
<ForeName>Georgina V</ForeName>
<Initials>GV</Initials>
<AffiliationInfo>
<Affiliation>Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Lancet Oncol</MedlineTA>
<NlmUniqueID>100957246</NlmUniqueID>
<ISSNLinking>1470-2045</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28884697</ArticleId>
<ArticleId IdType="pii">S1470-2045(17)30640-X</ArticleId>
<ArticleId IdType="doi">10.1016/S1470-2045(17)30640-X</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Nouvelle-Galles du Sud</li>
<li>Texas</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Boulogne-Billancourt</li>
<li>Sydney</li>
</settlement>
<orgName>
<li>Université de Sydney</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Davies, Michael A" sort="Davies, Michael A" uniqKey="Davies M" first="Michael A" last="Davies">Michael A. Davies</name>
</region>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Saiag, Philippe" sort="Saiag, Philippe" uniqKey="Saiag P" first="Philippe" last="Saiag">Philippe Saiag</name>
</region>
</country>
<country name="Australie">
<region name="Nouvelle-Galles du Sud">
<name sortKey="Long, Georgina V" sort="Long, Georgina V" uniqKey="Long G" first="Georgina V" last="Long">Georgina V. Long</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E19 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004E19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:28884697
   |texte=   Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:28884697" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024